Daniel Wilson to Dyslipidemias
This is a "connection" page, showing publications Daniel Wilson has written about Dyslipidemias.
Connection Strength
0.885
-
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging. 2015 Dec; 32(12):1055-65.
Score: 0.469
-
Prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic population aged = 65 years by lipid-lowering medication use status. Postgrad Med. 2010 Sep; 122(5):142-9.
Score: 0.326
-
Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. Am J Hypertens. 2009 Feb; 22(2):137-44.
Score: 0.072
-
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Am J Kidney Dis. 2009 May; 53(5):741-50.
Score: 0.018